Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
News + Filings
Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Seidel-Dugan Cynthia
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
01/09/2023
4
Seidel-Dugan Cynthia (Chief Scientific Officer) has filed a Form 4 on Werewolf Therapeutics, Inc.
Txns:
Granted 115,900 options to buy @ $2.05, valued at $237.6k
01/14/2022
4
Seidel-Dugan Cynthia (Chief Scientific Officer) has filed a Form 4 on Werewolf Therapeutics, Inc.
Txns:
Granted 79,516 options to buy @ $11.55, valued at $918.4k
Exercised 24,199 options to buy @ $1.56, valued at $37.8k
Exercised 15,532 options to buy @ $4.77, valued at $74.1k
05/04/2021
4
Form 4 - Statement of changes in beneficial ownership of securities:
04/29/2021
3
Form 3 - Initial statement of beneficial ownership of securities:
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy